{"id":25263,"date":"2014-06-10T09:26:03","date_gmt":"2014-06-10T13:26:03","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=25263"},"modified":"2014-06-10T09:26:03","modified_gmt":"2014-06-10T13:26:03","slug":"merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263","title":{"rendered":"Merck &amp; Co., Inc. (NYSE:MRK) To Buy Idenix To Extend Its Presence In Hepatitis C"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 06\/10\/2014 (wallstreetpr) \u2013 Global health care company <b>Merck &amp; Co., Inc. (NYSE:MRK) <\/b>announced that it struck a definite agreement to buy <b>Idenix Pharmaceuticals Inc (NASDAQ:IDIX)<\/b>, a bio-pharmaceutical company, for $3.85 billion. The acquisition is expected to help Merck widen its portfolio on Hepatitis C.<\/p>\n<p style=\"text-align: justify;\"><b>Acquisition of Idenix<\/b><\/p>\n<p style=\"text-align: justify;\">As part of the definitive deal, Merck &amp; Co., Inc. (NYSE:MRK). will pay $24.50 a share in cash for Idenix for a total purchase value of about $3.85 billion. The bio-pharmaceutical company has developed a potential portfolio consisting of hepatitis C candidates due to its expertise in the field of nucleotide chemistry or nucleoside besides prodrug technologies.<\/p>\n<p style=\"text-align: justify;\">Merck &amp; Co. believes that Idenix\u2019s new hepatitis candidates support its potential therapies in establishment besides helping advance its work to develop a drug with as far as possible the short duration of treatment that will help millions of patients around the globe. The potential drug candidate is expected to be once-daily, ribavirin-free, all oral, pan-genotypic regimen and highly effective.<\/p>\n<p style=\"text-align: justify;\">Idenix Pharmaceuticals Inc (NASDAQ:IDIX) believes that the deal creates value for its shareholder by aligning its strong portfolio of candidates with a well-known global healthcare company for its future success. The company has three drug candidates currently in its clinical development, and these candidates are being assessed for their likely inclusion in the development of pan-genotypic fixed dose, all oral combination regimens.<\/p>\n<p style=\"text-align: justify;\"><b>Tender Offer<\/b><\/p>\n<p style=\"text-align: justify;\">Merck &amp; Co. has indicated that it will launch a tender offer through its subsidiary to buy Idenix Pharmaceuticals\u2019 all outstanding shares and will close upon meeting certain conditions laid down in the deal as well as the regulations.<\/p>\n<p style=\"text-align: justify;\">After the closure of the tender officer, the global health care company has another option of buying all Idenix Pharmaceuticals Inc (NASDAQ:IDIX) shares by a second-step merger. The deal is expected to close in the third quarter of the current year.<\/p>\n<p style=\"text-align: justify;\">Merck &amp; Co., Inc. (NYSE:MRK). received financial advice from Credit Suisse, while Hughes Hubbard &amp; Reed LPP provided legal advice for the transaction. Idenix engaged Center view Partners as its financial advisor while Sullivan &amp; Cromwell was its legal advisor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 06\/10\/2014 (wallstreetpr) \u2013 Global health care company Merck &amp; Co., Inc. (NYSE:MRK) announced that it struck a definite agreement to buy Idenix Pharmaceuticals [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":15692,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[7210,1945,1683,3273,1946,1123],"stock_ticker":[],"class_list":["post-25263","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-idenix-pharmaceuticals-inc","tag-idenix-pharmaceuticals-inc-nasdaqidix","tag-merck-co-inc-nysemrk","tag-merck-co-inc","tag-nasdaqidix","tag-nysemrk","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck &amp; Co., Inc. (NYSE:MRK) To Buy Idenix To Extend Its Presence In Hepatitis C - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck &amp; Co., Inc. (NYSE:MRK) To Buy Idenix To Extend Its Presence In Hepatitis C - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 06\/10\/2014 (wallstreetpr) \u2013 Global health care company Merck &amp; Co., Inc. (NYSE:MRK) announced that it struck a definite agreement to buy Idenix Pharmaceuticals [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-06-10T13:26:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"750\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Steve Hackney\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Steve Hackney\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263\"},\"author\":{\"name\":\"Steve Hackney\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\"},\"headline\":\"Merck &amp; Co., Inc. (NYSE:MRK) To Buy Idenix To Extend Its Presence In Hepatitis C\",\"datePublished\":\"2014-06-10T13:26:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263\"},\"wordCount\":368,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg\",\"keywords\":[\"Idenix Pharmaceuticals Inc\",\"Idenix Pharmaceuticals Inc (NASDAQ:IDIX)\",\"Merck &amp; Co Inc. (NYSE:MRK)\",\"Merck &amp; Co. Inc.\",\"NASDAQ:IDIX\",\"NYSE:MRK\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263\",\"name\":\"Merck &amp; Co., Inc. (NYSE:MRK) To Buy Idenix To Extend Its Presence In Hepatitis C - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg\",\"datePublished\":\"2014-06-10T13:26:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg\",\"width\":1024,\"height\":750},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck &amp; Co., Inc. (NYSE:MRK) To Buy Idenix To Extend Its Presence In Hepatitis C\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867\",\"name\":\"Steve Hackney\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g\",\"caption\":\"Steve Hackney\"},\"description\":\"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck &amp; Co., Inc. (NYSE:MRK) To Buy Idenix To Extend Its Presence In Hepatitis C - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263","og_locale":"en_US","og_type":"article","og_title":"Merck &amp; Co., Inc. (NYSE:MRK) To Buy Idenix To Extend Its Presence In Hepatitis C - Wall Street PR","og_description":"Boston, MA 06\/10\/2014 (wallstreetpr) \u2013 Global health care company Merck &amp; Co., Inc. (NYSE:MRK) announced that it struck a definite agreement to buy Idenix Pharmaceuticals [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-06-10T13:26:03+00:00","og_image":[{"width":1024,"height":750,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg","type":"image\/jpeg"}],"author":"Steve Hackney","twitter_misc":{"Written by":"Steve Hackney","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263"},"author":{"name":"Steve Hackney","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867"},"headline":"Merck &amp; Co., Inc. (NYSE:MRK) To Buy Idenix To Extend Its Presence In Hepatitis C","datePublished":"2014-06-10T13:26:03+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263"},"wordCount":368,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg","keywords":["Idenix Pharmaceuticals Inc","Idenix Pharmaceuticals Inc (NASDAQ:IDIX)","Merck &amp; Co Inc. (NYSE:MRK)","Merck &amp; Co. Inc.","NASDAQ:IDIX","NYSE:MRK"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263","url":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263","name":"Merck &amp; Co., Inc. (NYSE:MRK) To Buy Idenix To Extend Its Presence In Hepatitis C - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg","datePublished":"2014-06-10T13:26:03+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Merck-Co.jpg","width":1024,"height":750},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-to-buy-idenix-to-extend-its-presence-in-hepatitis-c-25263#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Merck &amp; Co., Inc. (NYSE:MRK) To Buy Idenix To Extend Its Presence In Hepatitis C"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/3ce02e36ec0c7fc865d70f316a025867","name":"Steve Hackney","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d6e4a33d4904dade1e565fa07bb4bc099f7c12bc3da9ba57311e75086b1e91e8?s=96&d=mm&r=g","caption":"Steve Hackney"},"description":"Steve Hackney is a corporate finance professional with over 14 years of experience in cash management and investing. He earned a Bachelor of Science in Finance from Florida State University and holds a Certified Treasury Professional certification. Steve lives in Orlando, Florida with his family.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/steve-hackney"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/25263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=25263"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/25263\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/15692"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=25263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=25263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=25263"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=25263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}